IBDEI079 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9125,0)
 ;;=H40.11X3^^33^488^12
 ;;^UTILITY(U,$J,358.3,9125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9125,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,9125,1,4,0)
 ;;=4^H40.11X3
 ;;^UTILITY(U,$J,358.3,9125,2)
 ;;=^5005756
 ;;^UTILITY(U,$J,358.3,9126,0)
 ;;=H35.31^^33^488^13
 ;;^UTILITY(U,$J,358.3,9126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9126,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,9126,1,4,0)
 ;;=4^H35.31
 ;;^UTILITY(U,$J,358.3,9126,2)
 ;;=^5005647
 ;;^UTILITY(U,$J,358.3,9127,0)
 ;;=H35.32^^33^488^14
 ;;^UTILITY(U,$J,358.3,9127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9127,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,9127,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,9127,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,9128,0)
 ;;=E11.9^^33^488^15
 ;;^UTILITY(U,$J,358.3,9128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9128,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,9128,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,9128,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,9129,0)
 ;;=E11.39^^33^488^16
 ;;^UTILITY(U,$J,358.3,9129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9129,1,3,0)
 ;;=3^DM Type 2 w/ Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,9129,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,9129,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,9130,0)
 ;;=E11.329^^33^488^17
 ;;^UTILITY(U,$J,358.3,9130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9130,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9130,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,9130,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,9131,0)
 ;;=E11.339^^33^488^18
 ;;^UTILITY(U,$J,358.3,9131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9131,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9131,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,9131,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,9132,0)
 ;;=H59.039^^33^488^19
 ;;^UTILITY(U,$J,358.3,9132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9132,1,3,0)
 ;;=3^CME Mac Edema,Unspec Eye
 ;;^UTILITY(U,$J,358.3,9132,1,4,0)
 ;;=4^H59.039
 ;;^UTILITY(U,$J,358.3,9132,2)
 ;;=^5006396
 ;;^UTILITY(U,$J,358.3,9133,0)
 ;;=H43.391^^33^488^20
 ;;^UTILITY(U,$J,358.3,9133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9133,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,9133,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,9133,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,9134,0)
 ;;=H43.392^^33^488^21
 ;;^UTILITY(U,$J,358.3,9134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9134,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,9134,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,9134,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,9135,0)
 ;;=H02.831^^33^488^22
 ;;^UTILITY(U,$J,358.3,9135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9135,1,3,0)
 ;;=3^Dermatochalasis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,9135,1,4,0)
 ;;=4^H02.831
 ;;^UTILITY(U,$J,358.3,9135,2)
 ;;=^5004418
 ;;^UTILITY(U,$J,358.3,9136,0)
 ;;=H02.834^^33^488^23
 ;;^UTILITY(U,$J,358.3,9136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9136,1,3,0)
 ;;=3^Dermatochalasis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,9136,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,9136,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,9137,0)
 ;;=H10.31^^33^488^24
 ;;^UTILITY(U,$J,358.3,9137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9137,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,9137,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,9137,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,9138,0)
 ;;=H10.32^^33^488^25
 ;;^UTILITY(U,$J,358.3,9138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9138,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,9138,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,9138,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,9139,0)
 ;;=H00.11^^33^488^26
 ;;^UTILITY(U,$J,358.3,9139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9139,1,3,0)
 ;;=3^Chalazion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,9139,1,4,0)
 ;;=4^H00.11
 ;;^UTILITY(U,$J,358.3,9139,2)
 ;;=^5004233
 ;;^UTILITY(U,$J,358.3,9140,0)
 ;;=H00.14^^33^488^27
 ;;^UTILITY(U,$J,358.3,9140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9140,1,3,0)
 ;;=3^Chalazion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,9140,1,4,0)
 ;;=4^H00.14
 ;;^UTILITY(U,$J,358.3,9140,2)
 ;;=^5004236
 ;;^UTILITY(U,$J,358.3,9141,0)
 ;;=H20.00^^33^488^28
 ;;^UTILITY(U,$J,358.3,9141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9141,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,9141,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,9141,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,9142,0)
 ;;=B00.59^^33^488^29
 ;;^UTILITY(U,$J,358.3,9142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9142,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,9142,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,9142,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,9143,0)
 ;;=Z01.00^^33^488^30
 ;;^UTILITY(U,$J,358.3,9143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9143,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,9143,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,9143,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,9144,0)
 ;;=Z01.01^^33^488^31
 ;;^UTILITY(U,$J,358.3,9144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9144,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,9144,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,9144,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,9145,0)
 ;;=H10.31^^33^489^1
 ;;^UTILITY(U,$J,358.3,9145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9145,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,9145,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,9145,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,9146,0)
 ;;=H10.32^^33^489^2
 ;;^UTILITY(U,$J,358.3,9146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9146,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,9146,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,9146,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,9147,0)
 ;;=H10.401^^33^489^3
 ;;^UTILITY(U,$J,358.3,9147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9147,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Right Eye
 ;;^UTILITY(U,$J,358.3,9147,1,4,0)
 ;;=4^H10.401
 ;;^UTILITY(U,$J,358.3,9147,2)
 ;;=^5004681
 ;;^UTILITY(U,$J,358.3,9148,0)
 ;;=H10.402^^33^489^4
 ;;^UTILITY(U,$J,358.3,9148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9148,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Left Eye
 ;;^UTILITY(U,$J,358.3,9148,1,4,0)
 ;;=4^H10.402
 ;;^UTILITY(U,$J,358.3,9148,2)
 ;;=^5004682
 ;;^UTILITY(U,$J,358.3,9149,0)
 ;;=H10.403^^33^489^5
 ;;^UTILITY(U,$J,358.3,9149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9149,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Bilateral
 ;;^UTILITY(U,$J,358.3,9149,1,4,0)
 ;;=4^H10.403
 ;;^UTILITY(U,$J,358.3,9149,2)
 ;;=^5004683
 ;;^UTILITY(U,$J,358.3,9150,0)
 ;;=H10.45^^33^489^6
 ;;^UTILITY(U,$J,358.3,9150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9150,1,3,0)
 ;;=3^Conjunctivitis,Allergic,Chronic
 ;;^UTILITY(U,$J,358.3,9150,1,4,0)
 ;;=4^H10.45
 ;;^UTILITY(U,$J,358.3,9150,2)
 ;;=^87396
 ;;^UTILITY(U,$J,358.3,9151,0)
 ;;=B30.8^^33^489^7
 ;;^UTILITY(U,$J,358.3,9151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9151,1,3,0)
 ;;=3^Conjunctivitis,Viral
 ;;^UTILITY(U,$J,358.3,9151,1,4,0)
 ;;=4^B30.8
 ;;^UTILITY(U,$J,358.3,9151,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,9152,0)
 ;;=H10.13^^33^489^8
 ;;^UTILITY(U,$J,358.3,9152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9152,1,3,0)
 ;;=3^Conjunctivitis,Atopic,Bilateral
 ;;^UTILITY(U,$J,358.3,9152,1,4,0)
 ;;=4^H10.13
 ;;^UTILITY(U,$J,358.3,9152,2)
 ;;=^5004667
 ;;^UTILITY(U,$J,358.3,9153,0)
 ;;=H10.419^^33^489^9
 ;;^UTILITY(U,$J,358.3,9153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9153,1,3,0)
 ;;=3^Giant Papillary Conjunctivitis,Chronic
 ;;^UTILITY(U,$J,358.3,9153,1,4,0)
 ;;=4^H10.419
 ;;^UTILITY(U,$J,358.3,9153,2)
 ;;=^5004687
 ;;^UTILITY(U,$J,358.3,9154,0)
 ;;=H10.219^^33^489^10
 ;;^UTILITY(U,$J,358.3,9154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9154,1,3,0)
 ;;=3^Toxic Conjunctivitis,Acute
 ;;^UTILITY(U,$J,358.3,9154,1,4,0)
 ;;=4^H10.219
 ;;^UTILITY(U,$J,358.3,9154,2)
 ;;=^5004671
 ;;^UTILITY(U,$J,358.3,9155,0)
 ;;=M35.01^^33^489^11
 ;;^UTILITY(U,$J,358.3,9155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9155,1,3,0)
 ;;=3^Keratoconjunctivitis w/ Sicca Syndrome
 ;;^UTILITY(U,$J,358.3,9155,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,9155,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,9156,0)
 ;;=H11.31^^33^489^12
 ;;^UTILITY(U,$J,358.3,9156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9156,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,9156,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,9156,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,9157,0)
 ;;=H11.32^^33^489^13
 ;;^UTILITY(U,$J,358.3,9157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9157,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,9157,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,9157,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,9158,0)
 ;;=H15.101^^33^489^14
 ;;^UTILITY(U,$J,358.3,9158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9158,1,3,0)
 ;;=3^Episcleritis,Right Eye
 ;;^UTILITY(U,$J,358.3,9158,1,4,0)
 ;;=4^H15.101
 ;;^UTILITY(U,$J,358.3,9158,2)
 ;;=^5004835
 ;;^UTILITY(U,$J,358.3,9159,0)
 ;;=H15.102^^33^489^15
 ;;^UTILITY(U,$J,358.3,9159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9159,1,3,0)
 ;;=3^Episcleritis,Left Eye
 ;;^UTILITY(U,$J,358.3,9159,1,4,0)
 ;;=4^H15.102
 ;;^UTILITY(U,$J,358.3,9159,2)
 ;;=^5004836
 ;;^UTILITY(U,$J,358.3,9160,0)
 ;;=H15.001^^33^489^16
 ;;^UTILITY(U,$J,358.3,9160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9160,1,3,0)
 ;;=3^Scleritis,Right Eye
 ;;^UTILITY(U,$J,358.3,9160,1,4,0)
 ;;=4^H15.001
 ;;^UTILITY(U,$J,358.3,9160,2)
 ;;=^5004810
 ;;^UTILITY(U,$J,358.3,9161,0)
 ;;=H15.002^^33^489^17
 ;;^UTILITY(U,$J,358.3,9161,1,0)
 ;;=^358.31IA^4^2
